Photocure to present at the ABG Sundal Collier Virtual Oncology Seminar
Oslo, Norway, June 5, 2020 - Photocure ASA (OSE: PHO) will be presenting at the annual ABG Sundal Collier Virtual Oncology Seminar on June 10. This event features Norwegian companies in the oncology space.
The presentation is scheduled at 11:05 am CET and will be held remotely by Dan Schneider, President and CEO of Photocure ASA.
The presentation will be posted on www.Photocure.com prior to the presentation.
Company contacts:
Erik Dahl
Chief Financial Officer
Tel: +47 450 55 000
Email: ed@photocure.com
Media and IR enquiries:
Geir Bjørlo
Corporate Communications (Norway)
Tel: +47 91540000
Email: geir.bjorlo@corpcom.no
About Photocure
Photocure, The Bladder Cancer Company, delivers transformative solutions to improve the lives of bladder cancer patients. Our unique technology, which makes cancer cells glow bright pink, has led to better health outcomes for patients worldwide. Photocure is headquartered in Oslo, Norway, and listed on the Oslo Stock Exchange (OSE: PHO). For more information, please visit us at www.photocure.com, www.hexvix.com or www.cysview.com
